Quantitative determination of rofecoxib in pharmaceutical preparations.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000032:analysis*; D002851:Chromatography, High Pressure Liquid; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000032:analysis*; D000431:Ethanol; D007527:Isoenzymes / Q000378:metabolism; D007783:Lactones / Q000032:analysis*; D019999:Pharmaceutical Solutions; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism; D012015:Reference Standards; D012997:Solvents; D013056:Spectrophotometry, Ultraviolet; D013450:Sulfones; D013607:Tablets / Q000032:analysis
D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D007527:Isoenzymes; D007783:Lactones; D019999:Pharmaceutical Solutions; D012997:Solvents; D013450:Sulfones; D013607:Tablets; C116926:rofecoxib; D000431:Ethanol; D051546:Cyclooxygenase 2; D011451:Prostaglandin-Endoperoxide Synthases